An epitranscriptomic vulnerability in myeloid malignancies

Nature Medicine 23, 1252 (2017). doi:10.1038/nm.4435 Authors: Alexandra C Schmiechen & Pedro J Batista A recent study finds that the N6-methyladenosine (m6A) modifier METTL3 regulates proliferation and differentiation in myeloid cells and acute myeloid leukemia (AML).
Source: Nature Medicine - Category: General Medicine Authors: Tags: News and Views Source Type: research